Jerry Gin

Jerry Gin

Director/Board Member at VISTAGEN THERAPEUTICS, INC.

Net worth: 62 670 $ as of 2024-04-29

81 year
Health Technology
Consumer Services
Process Industries

Network origin in Jerry Gin first degree

EntityEntity typeIndustry
Public Company Biotechnology 24
7
Private Company Drugstore Chains 7
2
Subsidiary Pharmaceuticals: Major 2
2
Subsidiary Medical Specialties 2
Nuvora, Inc.
1
Private Company 1

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Jerry Gin via their personal network

CompanySectorRelated peopleMain position
AMD (ADVANCED MICRO DEVICES) Semiconductors

Indra Singhal

Corporate Officer/Principal

JOHNSON & JOHNSON Pharmaceuticals: Major

Richard J. Trevino

Maggie FitzPatrick

Corporate Officer/Principal

Public Communications Contact

Medical Specialties

Alan F. Russell

Carol F. H. Harner

General Counsel

Chief Tech/Sci/R&D Officer

Medical Specialties

Jon Saxe

Brian Underdown

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Richard J. Trevino

Corporate Officer/Principal

Investment Managers

Vernon G. Wong

Corporate Officer/Principal

QUESTCOR PHARMACEUTICALS INC Pharmaceuticals: Major

Jon Saxe

Mark Ginski

Director/Board Member

Corporate Officer/Principal

INTERMUNE INC Biotechnology

Richard J. Trevino

Corporate Officer/Principal

Semiconductors

Indra Singhal

Director of Finance/CFO

Medical Specialties

Indra Singhal

Corporate Officer/Principal

Pharmaceuticals: Major

Vernon G. Wong

Founder

Stanford University College/University

Mark Blumenkranz

Amit Goswamy

Corporate Officer/Principal

Masters Business Admin

George Washington University College/University

Reid Adler

Maggie FitzPatrick

Graduate Degree

Graduate Degree

College/University

Paula Johnson

Graduate Degree

Miscellaneous Commercial Services

Allen Cato

Shawn Singh

Chief Executive Officer

General Counsel

University of Utah College/University

Carol F. H. Harner

Louis Monti

Doctorate Degree

Doctorate Degree

Blackburn College College/University

Paula Johnson

Undergraduate Degree

The University of Texas at Austin College/University

Richard J. Trevino

Doctorate Degree

Yale University College/University

Mark A. Smith

Ann Cunningham

Graduate Degree

Undergraduate Degree

The Pennsylvania State University College/University

Indra Singhal

Joshua Prince

Graduate Degree

Masters Business Admin

University of California, Berkeley College/University

Shawn Singh

Rajiv Bhushan

Undergraduate Degree

Undergraduate Degree

University of Maryland College/University

Reid Adler

Mark Ginski

Undergraduate Degree

Doctorate Degree

Indian Institute of Technology Kharagpur College/University

Indra Singhal

Undergraduate Degree

Packaged Software

Paula Johnson

Founder

Pharmaceuticals: Major

Richard J. Trevino

Corporate Officer/Principal

Investment Managers

Allen Cato

Shawn Singh

Founder

Private Equity Investor

Cato Holding Co.

Shawn Singh

Chief Operating Officer

VistaGen, Inc.

Jon Saxe

Shawn Singh

H. Ralph Snodgrass

Chairman

Chief Executive Officer

Chief Executive Officer

Miscellaneous Commercial Services

Mark Flather

Mark McPartland

Investor Relations Contact

Corporate Officer/Principal

DMK PHARMACEUTICALS CORPORATION Pharmaceuticals: Major

Mark Flather

Trisha Fitzmaurice

Investor Relations Contact

Human Resources Officer

ECHO THERAPEUTICS, INC. Medical Specialties

Allen Cato

Shawn Singh

Director/Board Member

President

Investment Managers

Indra Singhal

Private Equity Investor

Hospital/Nursing Management

Ira Wong

Corporate Officer/Principal

The University of Maryland Francis King Carey School of Law College/University

Shawn Singh

Graduate Degree

Statistics

International

United States 43
Canada 2
India 2
Netherlands 2
Singapore 2

Sectoral

Health Technology 15
Consumer Services 14
Electronic Technology 5
Technology Services 5
Finance 4

Operational

Director/Board Member 102
Corporate Officer/Principal 78
Undergraduate Degree 26
President 26
Founder 24
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW